Manufacturing & Supply Chain

Reflecting Ireland’s position as a centre of excellence in life sciences and biopharmaceutical production, the Biopharma & Life Sciences Connected Live Conference and Exhibition will be held on Thursday, January 22nd 2026 at the Radisson Blu Hotel & Spa in Cork. The Conference will entail a full day’s schedule of keynote addresses and panel debates featuring leading national and international experts involved in the R&D and manufacturing of biopharmaceutical and biotech products and its associated technology. Accompanied by an Exhibition area displaying the latest technology and research, Biopharma & Life Sciences Connected Live will highlight the latest developments in the sector.

Ireland has become one of the world’s leading manufacturers of medicines. The world’s ten leading pharmaceutical companies have all established substantial operations in Ireland. Five of the world’s eight top selling drugs are currently produced in Ireland and the country has become the third largest exporter of pharmaceuticals globally. Supporting thousands of jobs and spread across the various regions, the Irish biopharmaceutical industry contributes significantly to both the national and local economies.

Winning Formula

The reasons for Ireland’s success in developing a thriving biopharmaceutical and life sciences sector are chiefly due to access to a well educated and talented workforce, the lower corporation tax regime, an economic environment that encourages R&D and innovation, along with a strong track record of both international and local companies operating successfully in the country.

IDA Ireland has played a key role in developing Ireland as a global pharmaceutical manufacturing and R&D hub and attracting Foreign Direct Investment (FDI) in the sector.

The Future of Biopharma in Ireland

The Biopharma & Life Sciences Connected Live Conference and Exhibition is timely following the recent publication by IDA Ireland of a comprehensive new whitepaper: ‘The Future of Biopharma in Ireland: Unlocking Growth Through Innovation, Investment, and Collaboration’. Based on contributions from several leading figures in Ireland’s biopharma sector, the report delivers current insights into Ireland’s evolving biopharmaceutical sector and maps out a strategic path to consolidate Ireland’s position as a global leader in biopharma manufacturing.

According to IDA Ireland, over the past 65 years, Ireland has grown into a major biopharma cluster, employing over 50,000 in a sector that has attracted €15 billion in foreign direct investment over the past decade. Providing a unique combination of innovation, regulatory excellence and collaborative industry-government efforts, Ireland is now poised for continued success in a rapidly changing global environment.

Major Challenges

However, despite its successful track record, the biopharma sector in Ireland is currently experiencing significant challenges around geopolitical shifts, supply chain issues, digital transformation, automation, carbon reduction and regulatory changes, and next-generation biologics. Biopharma & Life Sciences Connected Live will address these issues and offer practical advice on how they can be successfully managed. The Event will allow visitors to meet with Government support agencies and associations, and to join in Q&A sessions with industry thought leaders. Of course, Biopharma & Life Sciences Connected Live will provide an excellent networking opportunity for attendees.

Key Topics

Key topics to be covered by Biopharma & Life Sciences Connected Live include:

* Research & Innovation

* Automation

* Vaccine Manufacturing

* Process Optimization

* Tech Transfer

* Digitalization

* IoT & Industry 4.0

* Hybrid Systems – Single Use and/or Stainless Steel

* Biosimilars – Best-Practice

* Ultrafast Project Execution

* Turnkey

* HVAC & Cleanroom Engineering

* Cell & Gene Therapy.

Registration to attend Biopharma & Life Sciences Connected Live is now open. Register for free at: https://www.biotransformationevent.com/attendee-registration/